🔴 Chimeric Therapeutics is trading 5% down with no confirmed catalyst identified

Chimeric Therapeutics is trading 5% down at A$0.04, with no confirmed company-specific catalyst identified.

• No clear company-specific announcement dated August 14, 2026 was identified in available coverage.
• Recent financing and R&D-tax funding announcements predate the move.
• Broader U.S. markets were broadly flat, providing no strong macro explanation; the decline remains an unexplained company-level move.